2007
A United Kingdom supplier, with 3 awarded contracts, totalling £14.3m, most recently 6 months ago.
This contract involves the supply of a pharmaceutical product, specifically VAMOROLONE, marketed under the name AGAMREE. The required product is a 40mg/mL oral suspension in 100 mL packaging, with a total of 104 packages needed. The procurement is governed by Regulation 10 from November 17, 2011. Th
This contract involves construction and renovation activities related to the infrastructure network in the Vrabnitsa district of Sofia. The project specifically focuses on the construction of a parking area and access road near building 505 in the Vrabnitsa-1 residential complex. Suppliers are invit
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Burosumab, at a concentration of 30 mg/ml. This product is included in the list under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The contract is published on the
